For the Inventor, By the Inventor

Enter assignee name

Brighton, MA, United States of America

Compass Therapeutics LLC

USPTO Granted Patents = 15

Trademarks = 4

Forward Citations = 44

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Ugur Eskiocak (13 out of 14 patents)

Robert V Tighe, Iii (10 out of 10 patents)

Cheuk Lun Leung (10 out of 12 patents)

4. Michael March Schmidt (9 out of 9 patents)

5. Piotr Bobrowicz (8 out of 34 patents)

6. Paul Widboom (8 out of 8 patents)

7. Jason M Lajoie (7 out of 7 patents)

8. Bing Gong (3 out of 3 patents)

9. Rachel Rennard (3 out of 3 patents)

10. Amanda Frank Oliphant (3 out of 3 patents)

11. Benjamin Jacob Wolf (3 out of 4 patents)

12. Pearl Bakhru (3 out of 3 patents)

13. Diana I Albu (3 out of 3 patents)

15 patents: Sort by Forward Citations

1. 12503511 - MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOF (2025-12-23),

2. 12467062 - TRANSGENIC MOUSE EXPRESSING COMMON HUMAN LIGHT CHAIN (2025-11-11),

3. 12460004 - Antibodies that bind CD277 and uses thereof (2025-11-04),

4. 12286483 - Method of treating cancer using CD137 antibodies and PD-1 antagonists (2025-04-29),

5. 11970538 - Multispecific binding constructs against checkpoint molecules and uses thereof (2024-04-30),

6. 11851497 - CD137 antibodies and tumor antigen-targeting antibodies and uses thereof (2023-12-26),

7. 11752207 - Agonist antibodies that bind human CD137 and uses thereof (2023-09-12),

8. 11718679 - CD137 antibodies and PD-1 antagonists and uses thereof (2023-08-08),

9. 11046769 - Multispecific binding constructs against checkpoint molecules and uses thereof (2021-06-29),

10. 10716851 - Agonist antibodies that bind human CD137 and uses thereof (2020-07-21),

11. 10434175 - Agonist antibodies that bind human CD137 and uses thereof (2019-10-08),

12. 10350292 - Agonist antibodies that bind human CD137 and uses thereof (2019-07-16),

13. 10279040 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),

14. 10279039 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),

15. 10279038 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),

Compass Therapeutics is a biopharmaceutical company focused on the development of antibody therapeutics for the treatment of cancer and autoimmune diseases. The company utilizes its proprietary Translational Science Platform to identify novel drug targets and develop differentiated therapies. Compass Therapeutics aims to deliver first-in-class and best-in-class therapies to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Compass Therapeutics LLC

15 Patents

#2 in Brighton, MA

#1,271 in Massachusetts

#21,017 in US

#39,822 in the World

Brighton, MA, United States of America

Compass Therapeutics LLC

Forward Citations = 44

13 inventors:

Ugur Eskiocak (13 out of 14 patents)

Robert V Tighe, Iii (10 out of 10 patents)

Cheuk Lun Leung (10 out of 12 patents)

4. Michael March Schmidt (9 out of 9 patents)

5. Piotr Bobrowicz (8 out of 34 patents)

Please report any incorrect information to [email protected]

Loading…